Shenzhen Yonghe Shulian Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Yonghe Shulian Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SERENAGLOW. The owner is based in Shenzhen.

Room 101, No. 12, Lane 6, Dafapu East Village, Dafapu Community, Bantian Subdistrict, Longgang District

Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Shenzhen Yonghe Shulian Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Yonghe Shulian Technology Co., Ltd. have?

Shenzhen Yonghe Shulian Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Yonghe Shulian Technology Co., Ltd. file in?

Shenzhen Yonghe Shulian Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Yonghe Shulian Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Yonghe Shulian Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SERENAGLOW. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Yonghe Shulian Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Yonghe Shulian Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.